STOCK TITAN

Haleon (NYSE: HLN) reports director and PDMR share awards in January 2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Haleon plc reported routine share transactions by two senior executives under its Share Reward Plan. The company disclosed that on 5 January 2026, General Counsel Adrian Morris and Chief Marketing Officer Tamara Rogers, both classified as persons discharging managerial responsibilities (PDMRs), acquired ordinary shares in Haleon.

Each PDMR acquired 34 Partnership Shares in Haleon at a price of £3.71 per share and received an award of 34 Matching Shares at £0, giving an aggregated volume of 68 ordinary shares per person. The transactions took place on the London Stock Exchange and were reported in line with UK Market Abuse Regulation requirements.

Positive

  • None.

Negative

  • None.
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of January 2026
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
06 January 2026 - “Director/PDMR Shareholding”
 
 
99.1
 
 
Haleon plcDirector/PDMR Shareholding 
 
06 January 2026: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs").
 
On 6 January 2026, the Company received notification of the following transactions as detailed below.
 
 
 
Details of the person discharging managerial responsibilities / person closely associated  
 
a)  
 
Name  
 
Adrian Morris
 
 
Reason for the notification  
 
a)  
 
Position/status  
 
General Counsel - PDMR
b)  
 
Initial notification /Amendment  
 
Initial Notification 
 
 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
 
a)  
 
Name  
 
Haleon plc 
b)  
 
LEI  
 
549300PSB3WWEODCUP19 
 
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 
a)  
 
Description of the financial instrument, type of instrument  
Ordinary Shares of £0.01 each
 
 
Identification code  
GB00BMX86B70
 
 
b)  
 
Nature of the transaction  
 
Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan
c)  
 
Price(s) and volume(s)  
 
 
 
 
 
 
Price(s) 
Volume(s) 
 
 
 
£3.71
34
 
 
 
£Nil
34 (Matching Shares)
 
 
 
 
 
 
d)  
 
Aggregated information  
 
 
 
- Aggregated volume 
68
 
 
- Price 
 
 
 
e)  
 
Date of the transaction  
 
5 January 2026
f)  
 
Place of the transaction  
 
London Stock Exchange (XLON)
 
 
 
 
Details of the person discharging managerial responsibilities / person closely associated  
 
a)  
 
Name  
 
Tamara Rogers
 
 
Reason for the notification  
 
a)  
 
Position/status  
 
Chief Marketing Officer - PDMR
b)  
 
Initial notification /Amendment  
 
Initial Notification 
 
 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
 
a)  
 
Name  
 
Haleon plc 
b)  
 
LEI  
 
549300PSB3WWEODCUP19 
 
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 
a)  
 
Description of the financial instrument, type of instrument  
Ordinary Shares of £0.01 each
 
 
Identification code  
GB00BMX86B70
 
 
b)  
 
Nature of the transaction  
 
Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan
c)  
 
Price(s) and volume(s)  
 
 
 
 
 
 
Price(s) 
Volume(s) 
 
 
 
£3.71
34
 
 
 
£Nil
34 (Matching Shares)
 
 
 
 
 
 
d)  
 
Aggregated information  
 
 
 
- Aggregated volume 
68
 
 
- Price 
 
 
 
e)  
 
Date of the transaction  
 
5 January 2026
f)  
 
Place of the transaction  
 
London Stock Exchange (XLON)
 
 
Amanda Mellor
Company Secretary
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com.
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: January 06, 2026
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

What insider share transactions did Haleon (HLN) report in this 6-K filing?

Haleon reported that General Counsel Adrian Morris and Chief Marketing Officer Tamara Rogers each acquired 34 Partnership Shares at £3.71 and received 34 Matching Shares at £0 under the company’s Share Reward Plan.

Who are the Haleon PDMRs involved in the January 2026 share transactions?

The transactions involved Adrian Morris, General Counsel, and Tamara Rogers, Chief Marketing Officer, both classified as persons discharging managerial responsibilities (PDMRs) at Haleon plc.

On what date did the reported Haleon (HLN) PDMR share transactions occur?

The share transactions for both PDMRs took place on 5 January 2026 on the London Stock Exchange (XLON).

What type of Haleon shares were acquired by the PDMRs and at what price?

The PDMRs acquired Ordinary Shares of £0.01 each in Haleon. For each PDMR, 34 Partnership Shares were bought at £3.71 per share and 34 Matching Shares were awarded at £0.

What is the nature of the Haleon (HLN) Share Reward Plan transactions disclosed?

The transactions are described as the acquisition of Partnership Shares and the award of Matching Shares under Haleon’s Share Reward Plan, a company share-based incentive arrangement.

How many Haleon shares in total were involved for each PDMR in this filing?

For each of the two PDMRs, the aggregated volume was 68 ordinary shares, comprising 34 Partnership Shares purchased and 34 Matching Shares awarded.

Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

43.51B
4.45B
0.02%
12.85%
0.36%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge